1. Home
  2. CGEM vs VERI Comparison

CGEM vs VERI Comparison

Compare CGEM & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • VERI
  • Stock Information
  • Founded
  • CGEM 2016
  • VERI 2014
  • Country
  • CGEM United States
  • VERI United States
  • Employees
  • CGEM N/A
  • VERI N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • VERI EDP Services
  • Sector
  • CGEM Health Care
  • VERI Technology
  • Exchange
  • CGEM Nasdaq
  • VERI Nasdaq
  • Market Cap
  • CGEM 437.2M
  • VERI 438.8M
  • IPO Year
  • CGEM 2021
  • VERI 2017
  • Fundamental
  • Price
  • CGEM $8.53
  • VERI $4.27
  • Analyst Decision
  • CGEM Strong Buy
  • VERI Strong Buy
  • Analyst Count
  • CGEM 7
  • VERI 5
  • Target Price
  • CGEM $26.00
  • VERI $10.00
  • AVG Volume (30 Days)
  • CGEM 793.3K
  • VERI 6.7M
  • Earning Date
  • CGEM 11-06-2025
  • VERI 11-06-2025
  • Dividend Yield
  • CGEM N/A
  • VERI N/A
  • EPS Growth
  • CGEM N/A
  • VERI N/A
  • EPS
  • CGEM N/A
  • VERI N/A
  • Revenue
  • CGEM N/A
  • VERI $98,027,000.00
  • Revenue This Year
  • CGEM N/A
  • VERI $19.12
  • Revenue Next Year
  • CGEM N/A
  • VERI $18.83
  • P/E Ratio
  • CGEM N/A
  • VERI N/A
  • Revenue Growth
  • CGEM N/A
  • VERI 0.74
  • 52 Week Low
  • CGEM $5.68
  • VERI $1.22
  • 52 Week High
  • CGEM $14.15
  • VERI $9.42
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 58.64
  • VERI 37.84
  • Support Level
  • CGEM $7.93
  • VERI $3.94
  • Resistance Level
  • CGEM $9.10
  • VERI $4.51
  • Average True Range (ATR)
  • CGEM 0.66
  • VERI 0.54
  • MACD
  • CGEM 0.07
  • VERI -0.29
  • Stochastic Oscillator
  • CGEM 77.20
  • VERI 10.92

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.

Share on Social Networks: